Orbit Stocks Brings Hot Penny Stocks of This Morning - GRNH, CBIS, HEMP

Half Moon Bay, CA -- (SBWIRE) -- 02/05/2013 -- OrbitStocks.com is committed to discovering Awesome Penny Stock alerts with the potential to make large percent gains. Orbit Stocks have been in the penny stock market for several years and know how the game works. Their investing knowledge is a culmination of constant market analysis and trading experience. Orbit Stocks have a proven track record, and they provide their members with free, timely alerts.

GreenGro Technologies, Inc. (PINK:GRNH) reported a massive gain as market open, its shares surged 33.33% after opening at $0.13, while its recent trading price was $0.159. Total traded volume of the stock is 5.42 million till now, far higher than is average trading volume of 832,871.00 shares. Its total outstanding shares are 126.01 million while its total market capitalization stands at 20.26 million. Its beta value stood at 7.96 points.

For How Long GreenGro Technologies will Fight for Profitability? Read This Trend Analysis report

Stocks year to date performance remained quite optimistic with the gain of more than 320%. During last one month of trading its shares went up more than 250%.

GreenGro Technologies, has released clarity on what it calls its "Three Pillars to Success."

GRNH’s CFO David Rudat said that the company is ecstatic about recent sector coverage and the enthusiasm that our investors share with us for future expansion. We are, however, singularly focused on long-term growth and sustainability.

Cannabis Science Inc (PINK:CBIS) was also remained among Sharp gainers of the day as its shares went up 20.74% recently after opening at $0.10. Its recent trading price was $0.113.

CBIS is currently trading with the volume of 21.07 million shares while its average trading volume is 6.37 million shares. Its total market capitalization is 82.17 million. Stock’s 52 week trading price remained $0.03 - $0.25 and its beta value stood at 4.62 points.

Will CBIS Continue To Move Higher? Find Out Here

Cannabis Science reported its Corporate Operational Guidance for 2013, highlighting a strategic action plan to "bring to market" innovative, cannabinoid-based, life-saving, anti-cancer drugs. The Company anticipates releasing a variety of cannabinoid-based treatments that already show great promise in fighting HIV-related illnesses like Kaposi's Sarcoma that is on the rise due to the developing resistance to all current classes of anti-retroviral drugs.

Another active mover of the day is HEMP, INC. (PINK:HEMP), its opening price was $0.09 while recently its touched the trading price of $0.130. Recently the company gained 7.30 million shares volume along with its average trading volume of 8.22 million shares.

For How Long HEMP’s Gloss will Attract Investors? Find out via this report

During previous one month of trading stock gained 365.52% while in last 5 days of trading the company gained 389.13%. Also its YTD performance is quite optimistic with the score of 350%.

The company Hemp, Inc. (HEMP) has been dousing the industrial hemp market with hemp-based products, expanding its divisions and working to complete the spin-off of non-core related subsidiaries.

About OrbitStocks.com
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
Orbit Stocks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.